Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
Improved Skin Firmness and Elasticity Perhaps even more impressive than wrinkle reduction is the ability of copper peptides to restore skin elasticity
GLP-1 Pipeline Update: February 2025, Prime Therapeutics, 2025
(2021 - 2022) Member of the house of delegates of the American Medical Association
Many patients report: However, for patients with unresolved gut inflammation or adrenal dysfunction, semaglutide can exacerbate side effects such as nausea, fatigue, or constipation